Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Dec 13;53(13):8232-7.
doi: 10.1167/iovs.12-11025.

Mutations in RPGR and RP2 account for 15% of males with simplex retinal degenerative disease

Affiliations

Mutations in RPGR and RP2 account for 15% of males with simplex retinal degenerative disease

Kari Branham et al. Invest Ophthalmol Vis Sci. .

Abstract

Purpose: To determine the proportion of male patients presenting simplex retinal degenerative disease (RD: retinitis pigmentosa [RP] or cone/cone-rod dystrophy [COD/CORD]) with mutations in the X-linked retinal degeneration genes RPGR and RP2.

Methods: Simplex males were defined as patients with no known affected family members. Patients were excluded if they had a family history of parental consanguinity. Blood samples from a total of 214 simplex males with a diagnosis of retinal degeneration were collected for genetic analysis. The patients were screened for mutations in RPGR and RP2 by direct sequencing of PCR-amplified genomic DNA.

Results: We identified pathogenic mutations in 32 of the 214 patients screened (15%). Of the 29 patients with a diagnosis of COD/CORD, four mutations were identified in the ORF15 mutational hotspot of the RPGR gene. Of the 185 RP patients, three patients had mutations in RP2 and 25 had RPGR mutations (including 12 in the ORF15 region).

Conclusions: This study represents mutation screening of RPGR and RP2 in the largest cohort, to date, of simplex males affected with RP or COD/CORD. Our results demonstrate a substantial contribution of RPGR mutations to retinal degenerations, and in particular, to simplex RP. Based on our findings, we suggest that RPGR should be considered as a first tier gene for screening isolated males with retinal degeneration.

PubMed Disclaimer

Conflict of interest statement

Disclosure: K. Branham, None; M. Othman, None; M. Brumm, None; A.J. Karoukis, None; P. Atmaca-Sonmez, None; B.M. Yashar, None; S.B. Schwartz, None; N.B. Stover, None; K. Trzupek, None; D. Wheaton, None; B. Jennings, None; M.L. Ciccarelli, None; K.T. Jayasundera, None; R.A. Lewis, None; D. Birch, None; J. Bennett, None; P.A. Sieving, None; S. Andreasson, None; J.L. Duncan, None; G.A. Fishman, None; A. Iannaccone, None; R.G. Weleber, None; S.G. Jacobson, None; J.R. Heckenlively, None; A. Swaroop, None

Figures

Figure.
Figure.
RPGR mutations identified in this report. Novel mutations are italicized.

References

    1. Heckenlively JR. Retinitis Pigmentosa. Philadelphia, PA: JB Lippincott Company; 1988:6–24
    1. Boughman JA, Conneally PM, Nance WE. Population genetic studies of retinitis pigmentosa. Am J Hum Genet. 1980;32:223–235 - PMC - PubMed
    1. Bunker CH, Berson EL, Bromley WC, Hayes RP, Roderick TH. Prevalence of retinitis pigmentosa in Maine. Am J Ophthalmol. 1984;97:357–365 - PubMed
    1. Jay M. On the heredity of retinitis pigmentosa. Br J Ophthalmol. 1982;66:405–416 - PMC - PubMed
    1. Boughman JA, Fishman GA. A genetic analysis of retinitis pigmentosa. Br J Ophthalmol. 1983;67:449–454 - PMC - PubMed

Publication types